Kumanu, an Ann Arbor, Mich.-based wellbeing technology company, closed a $3m Series A funding.
ProMedica – a major nonprofit health system with 13 hospitals, more than 300 post-acute facilities, serving communities in 27 states, employing over 56,000, and contributing over $250 million in community benefit annually – made the investment. In conjunction with the funding, Randy Oostra, president and chief executive officer, ProMedica, joined Kumanu’s board of directors.
The company intends to use the funds to accelerate platform and market development around key areas including mental and social wellbeing, Social Determinants of Health (SDOH), and the application of purpose science to promote pro-social behaviors related to inclusion and belonging. Alongside the strategic investment, Kumanu and ProMedica will jointly develop solutions to intervene against risks driven by Social Determinants of Health — the social, economic, and environmental factors that impact health risks and outcomes. These risks include factors such as food insecurity, financial strain, housing, behavioral health, transportation, violence risks, and childcare.
Led by Victor Strecher, PhD, MPH, founder and chief executive officer, Kumanu provides a platform that combines neuroscience research with behavior design principles and machine learning to allow individuals to be their best each day, increase resilience, and achieve enduring behavior change. The investment comes on the heels of a year in which Kumanu introduced its new brand, re-launched its AI-driven purpose activation platform, released its flagship application Purposeful by Kumanu™, and forged partnerships with leading technology companies, health care systems, universities, and Medicare plans.